Annual CFF
$13.82 M
+$13.20 M+2150.49%
31 December 2023
Summary:
Assembly Biosciences annual cash flow from financing activities is currently $13.82 million, with the most recent change of +$13.20 million (+2150.49%) on 31 December 2023. During the last 3 years, it has risen by +$6.22 million (+81.84%). ASMB annual CFF is now -91.35% below its all-time high of $159.79 million, reached on 31 December 2018.ASMB Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$0.00
-$12.45 M-100.00%
30 September 2024
Summary:
Assembly Biosciences quarterly cash flow from financing activities is currently $0.00, with the most recent change of -$12.45 million (-100.00%) on 30 September 2024. Over the past year, it has stayed the same.ASMB quarterly CFF is now -100.00% below its all-time high of $155.84 million, reached on 30 September 2018.ASMB Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$21.65 M
$0.000.00%
30 September 2024
Summary:
Assembly Biosciences TTM cash flow from financing activities is currently $21.65 million, unchanged on 30 September 2024. Over the past year, it has increased by +$16.58 million (+327.53%). ASMB TTM CFF is now -90.40% below its all-time high of $225.42 million, reached on 30 September 2018.ASMB TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ASMB Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2150.5% | 0.0% | +327.5% |
| 3 y3 years | +81.8% | -100.0% | -61.4% |
| 5 y5 years | -91.3% | -100.0% | +663.3% |
ASMB Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -74.0% | +2150.5% | -100.0% | -61.4% | +3425.4% | |
| 5 y | 5 years | -91.3% | +2150.5% | -100.0% | -84.5% | +3425.4% | |
| alltime | all time | -91.3% | +8931.4% | -100.0% | -90.4% |
Assembly Biosciences Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $0.00(-100.0%) | $21.65 M(0.0%) |
| June 2024 | - | $12.45 M(>+9900.0%) | $21.65 M(+132.1%) |
| Mar 2024 | - | $0.00(-100.0%) | $9.33 M(-32.5%) |
| Dec 2023 | $13.82 M(+2150.5%) | $9.19 M(>+9900.0%) | $13.82 M(+172.9%) |
| Sept 2023 | - | $0.00(-100.0%) | $5.06 M(0.0%) |
| June 2023 | - | $134.00 K(-97.0%) | $5.06 M(-0.8%) |
| Mar 2023 | - | $4.49 M(+927.9%) | $5.11 M(+731.6%) |
| Dec 2022 | $614.00 K(-98.8%) | $437.00 K(>+9900.0%) | $614.00 K(-78.8%) |
| Sept 2022 | - | $0.00(-100.0%) | $2.89 M(-77.7%) |
| June 2022 | - | $177.00 K(>+9900.0%) | $12.95 M(-31.6%) |
| Mar 2022 | - | $0.00(-100.0%) | $18.93 M(-64.3%) |
| Dec 2021 | $53.06 M(+598.3%) | $2.71 M(-73.0%) | $53.06 M(-5.3%) |
| Sept 2021 | - | $10.05 M(+63.3%) | $56.04 M(+19.7%) |
| June 2021 | - | $6.16 M(-82.0%) | $46.83 M(+12.5%) |
| Mar 2021 | - | $34.14 M(+500.3%) | $41.62 M(+447.7%) |
| Dec 2020 | $7.60 M(-94.6%) | $5.69 M(+574.6%) | $7.60 M(-94.5%) |
| Sept 2020 | - | $843.00 K(-11.3%) | $139.33 M(-0.4%) |
| June 2020 | - | $950.00 K(+698.3%) | $139.87 M(+0.2%) |
| Mar 2020 | - | $119.00 K(-99.9%) | $139.63 M(-0.0%) |
| Dec 2019 | $139.65 M(-12.6%) | $137.41 M(+9821.7%) | $139.65 M(+4824.0%) |
| Sept 2019 | - | $1.39 M(+96.2%) | $2.84 M(-98.2%) |
| June 2019 | - | $706.00 K(+404.3%) | $157.29 M(-0.7%) |
| Mar 2019 | - | $140.00 K(-76.9%) | $158.44 M(-0.8%) |
| Dec 2018 | $159.79 M(+137.6%) | $605.00 K(-99.6%) | $159.79 M(-29.1%) |
| Sept 2018 | - | $155.84 M(+8324.0%) | $225.42 M(+222.8%) |
| June 2018 | - | $1.85 M(+23.8%) | $69.84 M(+2.6%) |
| Mar 2018 | - | $1.49 M(-97.7%) | $68.09 M(+1.3%) |
| Dec 2017 | $67.24 M(>+9900.0%) | $66.23 M(>+9900.0%) | $67.24 M(+5677.1%) |
| Sept 2017 | - | $262.90 K(+143.4%) | $1.16 M(+29.2%) |
| June 2017 | - | $108.00 K(-83.1%) | $901.00 K(+13.6%) |
| Mar 2017 | - | $640.00 K(+318.3%) | $793.00 K(+418.3%) |
| Dec 2016 | $153.00 K | $153.00 K(>+9900.0%) | $153.00 K(>+9900.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2016 | - | $0.00(0.0%) | $0.00(-100.0%) |
| June 2016 | - | $0.00(0.0%) | $257.40 K(-97.6%) |
| Mar 2016 | - | $0.00(0.0%) | $10.90 M(-86.6%) |
| Dec 2015 | $81.57 M(+387.7%) | $0.00(-100.0%) | $81.57 M(-15.5%) |
| Sept 2015 | - | $257.40 K(-97.6%) | $96.53 M(+0.3%) |
| June 2015 | - | $10.64 M(-84.9%) | $96.27 M(+12.4%) |
| Mar 2015 | - | $70.67 M(+372.3%) | $85.63 M(+412.0%) |
| Dec 2014 | $16.73 M(-31.4%) | $14.96 M(>+9900.0%) | $16.73 M(+738.3%) |
| Sept 2014 | - | $0.00(0.0%) | $2.00 M(-62.9%) |
| June 2014 | - | $0.00(-100.0%) | $5.38 M(0.0%) |
| Mar 2014 | - | $1.76 M(+659.6%) | $5.38 M(-77.9%) |
| Dec 2013 | $24.37 M(+397.8%) | $232.10 K(-93.1%) | $24.37 M(+1.0%) |
| Sept 2013 | - | $3.39 M(>+9900.0%) | $24.14 M(+16.3%) |
| June 2013 | - | $0.00(-100.0%) | $20.75 M(-18.5%) |
| Mar 2013 | - | $20.75 M(>+9900.0%) | $25.47 M(+420.1%) |
| Dec 2012 | $4.90 M(-89.7%) | $0.00(0.0%) | $4.90 M(-0.3%) |
| Sept 2012 | - | $0.00(-100.0%) | $4.91 M(-90.4%) |
| June 2012 | - | $4.72 M(+2509.9%) | $50.91 M(+9.7%) |
| Mar 2012 | - | $180.70 K(+1219.0%) | $46.41 M(-2.3%) |
| Dec 2011 | $47.49 M(+141.0%) | $13.70 K(-100.0%) | $47.49 M(-24.6%) |
| Sept 2011 | - | $45.99 M(>+9900.0%) | $62.99 M(+257.1%) |
| June 2011 | - | $220.00 K(-82.5%) | $17.64 M(-3.0%) |
| Mar 2011 | - | $1.26 M(-91.9%) | $18.18 M(-7.7%) |
| Dec 2010 | $19.70 M(+454.8%) | $15.52 M(+2315.3%) | $19.70 M(+267.2%) |
| Sept 2010 | - | $642.50 K(-16.1%) | $5.37 M(+2.5%) |
| June 2010 | - | $765.60 K(-72.4%) | $5.23 M(+4.5%) |
| Mar 2010 | - | $2.78 M(+135.3%) | $5.01 M(+41.0%) |
| Dec 2009 | $3.55 M(+42.2%) | $1.18 M(+131.5%) | $3.55 M(+49.8%) |
| Sept 2009 | - | $510.00 K(-5.6%) | $2.37 M(+27.4%) |
| June 2009 | - | $540.50 K(-59.1%) | $1.86 M(+40.9%) |
| Mar 2009 | - | $1.32 M | $1.32 M |
| Dec 2008 | $2.50 M | - | - |
FAQ
- What is Assembly Biosciences annual cash flow from financing activities?
- What is the all time high annual CFF for Assembly Biosciences?
- What is Assembly Biosciences annual CFF year-on-year change?
- What is Assembly Biosciences quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Assembly Biosciences?
- What is Assembly Biosciences quarterly CFF year-on-year change?
- What is Assembly Biosciences TTM cash flow from financing activities?
- What is the all time high TTM CFF for Assembly Biosciences?
- What is Assembly Biosciences TTM CFF year-on-year change?
What is Assembly Biosciences annual cash flow from financing activities?
The current annual CFF of ASMB is $13.82 M
What is the all time high annual CFF for Assembly Biosciences?
Assembly Biosciences all-time high annual cash flow from financing activities is $159.79 M
What is Assembly Biosciences annual CFF year-on-year change?
Over the past year, ASMB annual cash flow from financing activities has changed by +$13.20 M (+2150.49%)
What is Assembly Biosciences quarterly cash flow from financing activities?
The current quarterly CFF of ASMB is $0.00
What is the all time high quarterly CFF for Assembly Biosciences?
Assembly Biosciences all-time high quarterly cash flow from financing activities is $155.84 M
What is Assembly Biosciences quarterly CFF year-on-year change?
Over the past year, ASMB quarterly cash flow from financing activities has changed by $0.00 (0.00%)
What is Assembly Biosciences TTM cash flow from financing activities?
The current TTM CFF of ASMB is $21.65 M
What is the all time high TTM CFF for Assembly Biosciences?
Assembly Biosciences all-time high TTM cash flow from financing activities is $225.42 M
What is Assembly Biosciences TTM CFF year-on-year change?
Over the past year, ASMB TTM cash flow from financing activities has changed by +$16.58 M (+327.53%)